Supriya Lifescience Limited — Others, 11-04-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Supriya Lifescience Limited has announced a board meeting to review the financial results for the quarter and half-year ended March 31, 2025. The company has received a compliance certificate confirming that securities received for dematerialisation during the quarter have been processed and listed on the appropriate exchanges. This compliance reinforces the company's operational transparency and aligns with corporate governance standards.

From an investor's perspective, this development reflects positively on Supriya Lifescience's commitment to maintaining regulatory compliance, potentially enhancing investor confidence in the company's operational integrity and financial health.